RACHEL LEVY-HAIM: Open Payments
NPI 1588170245 · WOODHAVEN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$860 in 30 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $860
Food & beverage: $860
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 5 | $237 |
| AstraZeneca Pharmaceuticals LP | 4 | $197 |
| Novartis Pharmaceuticals Corporation | 11 | $150 |
| Novo Nordisk Inc | 3 | $149 |
| Merck Sharp & Dohme LLC | 7 | $126 |
Products named: CAMZYOS, LEQVIO, Wegovy, VERQUVO, LOKELMA, FARXIGA, ELIQUIS, Rybelsus.
Industry payments across NY — which companies pay providers there.
